As of May, 1 Intersect ENT, Inc. (XENT) EPS Estimated At $

Remigio Civitarese
Aprile 22, 2018

Over the last quarter, insiders have sold 84,457 shares of company stock worth $3,153,971. Last quarter $-0.11 earnings per share was reported.

Intersect ENT, Inc, a drug delivery company, researches and develops products for the treatment of patients with ear, nose and throat conditions in the United States. (NYSE:NRG) to report $-0.09 EPS on May, 1.They anticipate $0.43 EPS change or 82.69% from last quarter's $-0.52 EPS. XENT has 132,664 shares volume. Intersect ENT, Inc. (NASDAQ:XENT) has risen 124.86% since April 21, 2017 and is uptrending. XENT outperformed by 113.31% the S&P500.

Hilltop Holdings Inc increased its stake in Johnson & Johnson (JNJ) by 18.61% based on its latest 2017Q4 regulatory filing with the SEC. Dorsey Wright & Associates acquired 91,651 shares as Ing Groep N V Sponsored Adr (ING)'s stock declined 9.85%. The institutional investor held 20,379 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.85M, up from 17,181 at the end of the previous reported quarter. The company has a market capitalization of $1,235.42, a P/E ratio of -74.20 and a beta of 0.75. About 86,700 shares traded. It has underperformed by 0.48% the S&P500. About 246,014 shares traded or 0.05% up from the average. 71 funds opened positions while 114 raised stakes. (CAP) by 126,334 shares in the quarter, and has risen its stake in. Tudor Invest Et Al holds 27,304 shares or 0.02% of its portfolio. Massachusetts Finance Svcs Ma invested in 29.17M shares. Anchor Cap Advsr Ltd Liability Corp stated it has 0.97% in Johnson & Johnson (NYSE:JNJ). (NYSE:NRG). Wells Fargo Mn owns 299,294 shares for 0% of their portfolio. Stelac Advisory Serv Limited Liability Corporation invested in 772 shares or 0.05% of the stock. 305.48 million shares or 10.25% more from 277.07 million shares in 2017Q3 were reported. Plante Moran Fin Advsrs Ltd reported 249 shares. (NYSE:NRG). Atlantic Trust Group Ltd Co accumulated 0% or 1,018 shares. Supplemental Annuity Collective Tru Of Nj has 31,934 shares. In Tuesday, January 2 report JP Morgan upgraded the stock to "Overweight" rating. Therefore 48% are positive. (NASDAQ:XENT) has "Buy" rating given on Monday, October 16 by Canaccord Genuity. The stock of Johnson & Johnson (NYSE:JNJ) has "Sell" rating given on Wednesday, August 2 by BTIG Research. The company was maintained on Tuesday, September 29 by Piper Jaffray. (NASDAQ:JJSF) earned "Neutral" rating by DA Davidson on Wednesday, January 4. Northland Securities boosted their price target on Intersect ENT from $17.00 to $22.00 and gave the stock an outperform rating in a report on Thursday, May 4th. (NASDAQ:XENT)'s quarterly earnings on May, 1., according to Zacks. For the next fiscal year, analysts forecast that the business will report sales of $146.96 million per share, with estimates ranging from $137.30 million to $160.97 million.

Kopp Investment Advisors Llc, which manages about $252.21M and $99.84 million US Long portfolio, upped its stake in Celgene Corp. At present, 3 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. Therefore 40% are positive.

ILLEGAL ACTIVITY NOTICE: "Insider Selling: Intersect ENT (XENT) CFO Sells 12,833 Shares of Stock" was originally reported by and is owned by of The stock rating was maintained by Canaccord Genuity with "Buy" on Thursday, January 4. Northland Capital maintained Intersect ENT, Inc. (NASDAQ:XENT) on Wednesday, August 2 with "Hold" rating. Finally, Zacks Investment Research upgraded Intersect ENT from a "sell" rating to a "hold" rating in a research report on Wednesday, February 28th. TIAA CREF Investment Management LLC increased its stake in Intersect ENT by 7.7% during the 4th quarter. The firm has "Buy" rating given on Wednesday, December 6 by Canaccord Genuity. The stock has "Buy" rating by Deutsche Bank on Wednesday, August 2. On Monday, October 30 the stock rating was maintained by BTIG Research with "Buy".

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE